PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 159 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 2.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $144,000 | +17.1% | 2,937 | -23.2% | 0.01% | +16.7% |
| Q2 2018 | $123,000 | -37.2% | 3,826 | -39.3% | 0.01% | -40.0% |
| Q1 2018 | $196,000 | +41.0% | 6,308 | +106.5% | 0.02% | +33.3% |
| Q4 2017 | $139,000 | +26.4% | 3,055 | +4.5% | 0.02% | +15.4% |
| Q3 2017 | $110,000 | -17.3% | 2,923 | +4.6% | 0.01% | -23.5% |
| Q2 2017 | $133,000 | +16.7% | 2,794 | +12.2% | 0.02% | 0.0% |
| Q1 2017 | $114,000 | +165.1% | 2,491 | +85.6% | 0.02% | +142.9% |
| Q4 2016 | $43,000 | +207.1% | 1,342 | +571.0% | 0.01% | +133.3% |
| Q2 2015 | $14,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |